Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?
π Celsius Holdings reported FY 2025 revenue of $2.5 billion, representing an 85.5% increase year-over-year.
β οΈ Nearly 43.2% of Celsius's total net revenue came from its primary partner, Pepsi, as of December 31, 2025.
π° Colgate-Palmolive generated $2.1 billion in net income during FY 2025 on a revenue base of nearly $20.4 billion.
π Celsius stock price has declined by approximately 54% over the last 12 months despite recent top-line growth.
π Colgate-Palmolive shares have increased by nearly 22%, outperforming both Celsius and the S&P 500's 14.3% return.
π Colgate-Palmolive has increased its dividend payout for 63 consecutive years, qualifying it as a Dividend King.
βοΈ The article identifies significant customer concentration risk for Celsius due to its heavy dependency on Pepsi for distribution and strategy.
π‘οΈ Colgate-Palmolive faces risks related to macroeconomic instability, inflationary pressures, and currency fluctuations across its global operations.
π Motley Fool analysts explicitly excluded Celsius Holdings from their list of 10 best stocks to buy now, favoring Colgate instead.
- Colgate-Palmolive has increased its dividend payout for 63 consecutive years, establishing a strong track record as a Dividend King.
- The company generated approximately $2.1 billion in net income during FY 2025, demonstrating robust profitability on a revenue base of nearly $20.4 billion.
- Colgate shares have risen by nearly 22% over the last 12 months, significantly outperforming the S&P 500's 14.3% return and rival Celsius Holdings.
- Inflationary pressures and currency fluctuations can drive up costs for raw materials, logistics, and labor across different regions.
- Colgate-Palmolive faces vigorous competition from multinational brands and private-label products requiring constant adaptation to the digital retail landscape.